Exobiosphere Funding Round

8/11/2026

Venture Equity

$105,000

Undisclosed

The aid will support Exobiosphere's operations, commercial expansion, international business development and marketing, while helping the company scale its orbital high-throughput screening platform.

Private & Independent

Biopharmaceutical

29, Rue Henri Koch
Esch-sur-Alzette, L-4354
Luxembourg

Undisclosed

At Exobiosphere, our mission is to extend and improve life on Earth and in Space. We use microgravity as a new dimension for biology to accelerate drug discovery and unlock therapies that are very hard or even impossible to develop on Earth.We're building the world's first standardized space-based high-throughput testing platform, allowing pharma and biotech partners to run automated experiments in orbit, at scale. By combining microgravity with advanced lab automation and bioinformatics, we create more physiologically relevant models, observe faster disease development, and reach enhanced 3D biology compared to standard in-vitro systems.